The improved economic conditions enjoyed by lower-income consumers stimulated sales of medicated skin care products in 2011. Historically, minor parasitic infestations and fungal infections had to be ignored by a large number of Brazilians, with limited access to healthcare services and insufficient income to spend on what was perceived to be non-essential medication. This state of affairs began to change in the last decade. The growth experienced during the review period can largely be...
Euromonitor International's Medicated Skin Care in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Medicated Skin Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Click for Report details:Medicated Skin Care in Brazil - Market Research Report
